Slides
Page 1
Altimmune R & D Day Pemvidutide : Designed to be the Treatment of Choice for Liver and Cardiometabolic Diseases MARCH 13 , 2025 altimmune
Loading workspace
Altimmune R & D Day Pemvidutide : Designed to be the Treatment of Choice for Liver and Cardiometabolic Diseases MARCH 13 , 2025 altimmune
Your watchlist and earnings event details are available after you sign in.